GLMD Stock Analysis: Buy, Sell, or Hold?
GLMD - Galmed Pharmaceuticals Ltd.
$0.61
-0.09 (-13.07%)
▼
5d:
-16.8%
30d:
-3.42%
90d:
-1.67%
WAIT
LOW Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: Jun 11, 2026
2d
Get Alerted When GLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: GLMD is down 16.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: GLMD is down 16.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: GLMD is currently trading at $0.61, which is considered fair relative to its 30-day fair value range of $0.57 to $0.68.
Technical Outlook: Technically, GLMD is in a downtrend. Immediate support is located at $0.57, while resistance sits at $0.79. Short-term momentum is weak, with the stock down 13.1% recently.
Market Sentiment: GLMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.00 (+1624.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GLMD is in a downtrend. Immediate support is located at $0.57, while resistance sits at $0.79. Short-term momentum is weak, with the stock down 13.1% recently.
Market Sentiment: GLMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.00 (+1624.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.57 -
$0.68
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
76.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-13.1%)
- BULLISH: Trading 1624.1% below Wall St target ($12.00)
- WARNING: Recommendation downgraded due to -16.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.57 -
$0.68
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.57
Resistance Level
$0.79
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.77
Wall Street Target
$12.00
(+1624.1%)
Share & Embed Analysis
Last updated: June 08, 2026 11:40 AM ET
Data refreshes hourly during market hours. Next update: 12:40 PM
Data refreshes hourly during market hours. Next update: 12:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 59 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 57 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$253 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 53 HOLD |
